Recon: Supreme Court won’t review Oklahoma PBM law; Senate passes megabill after marathon voting session

ReconReconBiologics/ biosimilars/ vaccinesEuropean CommissionGlobalGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUS Food and Drug Administration (FDA)